Role of alternative splicing signatures in the prognosis of glioblastoma.

Zu-Cheng XieHua-Yu WuYi-Wu DangGang Chen

Published in: Cancer medicine (2019)

Applying the prognostic signatures constructed by independent AS events shows promise for predicting the survival of GBM patients. A splicing regulatory network might be the potential splicing mechanism in GBM.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
genome wide
peritoneal dialysis
prognostic factors
gene expression
risk assessment
machine learning
network analysis